30 days of immunotherapy education and awareness programming for patients, caregivers, and the general public celebrating advances in immuno-oncology research and treatment
Cancer Research Institute has published a comprehensive analysis of the current clinical trial landscape of anti PD-1/L1 immune checkpoint inhibitors.
The Cancer Research Institute has published an updated global immuno-oncology landscape analysis highlighting a robust pipeline marked by rapid growth.
The study explores a potential non-invasive approach to identify tumor mutations.
Drs. Miriam Merad and Padmanee Sharma will be honored with the 2018 William B. Coley Award, while Dr. Boris Reizis will receive the Frederick W. Alt Award
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Effective treatments and patient response are the focus of the world’s largest clinical cancer conference when it returns to Chicago May 31-June 4, 2019.
Get your summer fun and summer fundraising ideas rolling in support of high-impact cancer immunotherapy research. Become a champion fundraiser this summer.